The Impact of Novel Radiation Treatment Techniques on Toxicity and Clinical Outcomes in Rectal Cancer
作者： Lara Hathout , Terence Williams , Salma K. Jabbour
DOI: 10.1007/S11888-017-0351-Z
关键词: Brachytherapy 、 Colorectal surgery 、 Nuclear medicine 、 Standard technique 、 Medicine 、 Toxicity 、 Proton therapy 、 Colorectal cancer 、 Radiation therapy 、 Stereotactic body radiation therapy
摘要: Purpose of Review Three-dimensional conformal radiation therapy (3DCRT) has been the standard technique in treatment rectal cancer. The use new technologies such as intensity-modulated (IMRT), proton (PT), stereotactic body (SBRT), and brachytherapy (BT) increasing over past 10 years. This review will highlight advantages drawbacks these techniques.
springer.com
sci-hub.se 参考文章(89)
Té Vuong, Slobodan Devic, High-dose-rate pre-operative endorectal brachytherapy for patients with rectal cancer. Journal of Contemporary Brachytherapy. ,vol. 7, pp. 183- 188 ,(2015) , 10.5114/JCB.2015.51402
William M. Mendenhall, Bradford S. Hoppe, Nataliya Getman, Rovel J. Colaco, Soon Huh, Christopher G. Morris, Romaine Charles Nichols, Nancy P. Mendenhall, Zuofeng Li, Meng Wei Ho, Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer Journal of gastrointestinal oncology. ,vol. 5, pp. 3- 8 ,(2014) , 10.3978/J.ISSN.2078-6891.2013.041
Nergiz Dagoglu, Anand Mahadevan, Elena Nedea, Vitaly Poylin, Deborah Nagle, Stereotactic body radiotherapy (SBRT) reirradiation for pelvic recurrence from colorectal cancer. Journal of Surgical Oncology. ,vol. 111, pp. 478- 482 ,(2015) , 10.1002/JSO.23858
Improved survival with preoperative radiotherapy in resectable rectal cancer. The New England Journal of Medicine. ,vol. 336, pp. 980- 987 ,(1997) , 10.1056/NEJM199704033361402
Theodore S. Hong, Jennifer Moughan, Michael C. Garofalo, Johanna Bendell, Adam C. Berger, Nicklas B.E. Oldenburg, Pramila Rani Anne, Francisco Perera, R. Jeffrey Lee, Salma K. Jabbour, Adam Nowlan, Albert DeNittis, Christopher Crane, NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer International Journal of Radiation Oncology Biology Physics. ,vol. 93, pp. 29- 36 ,(2015) , 10.1016/J.IJROBP.2015.05.005
U. Metzger, Adjuvant therapy for colon and rectal cancer. NIH Consensus Development Conference. European Journal of Cancer and Clinical Oncology. ,vol. 26, pp. 753- 755 ,(1990) , 10.1016/0277-5379(90)90136-H
Kathryn McCarthy, Katherine Pearson, Rachel Fulton, Jonathan Hewitt, None, Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer. Cochrane Database of Systematic Reviews. ,vol. 12, ,(2012) , 10.1002/14651858.CD008368.PUB2
Lisa A Kachnic, Kevan L Hartshorn, Itai Pashtan, Minh Tam Truong, Arti Parekh, Neil E Martin, John Willins, Muhammad M Qureshi, Omer Nawaz, Sandra Cerda, Acute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancer. Gastrointestinal Cancer Research : GCR. ,vol. 6, pp. 137- 143 ,(2013)
Claus Rödel, Ullrich Graeven, Rainer Fietkau, Werner Hohenberger, Torsten Hothorn, Dirk Arnold, Ralf-Dieter Hofheinz, Michael Ghadimi, Hendrik A Wolff, Marga Lang-Welzenbach, Hans-Rudolf Raab, Christian Wittekind, Philipp Ströbel, Ludger Staib, Martin Wilhelm, Gerhard G Grabenbauer, Hans Hoffmanns, Fritz Lindemann, Anke Schlenska-Lange, Gunnar Folprecht, Rolf Sauer, Torsten Liersch, German Rectal Cancer Study Group, None, Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial The Lancet Oncology. ,vol. 16, pp. 979- 989 ,(2015) , 10.1016/S1470-2045(15)00159-X
M. B. Nielsen, S. Laurberg, T. Holm, Current management of locally recurrent rectal cancer. Colorectal Disease. ,vol. 13, pp. 732- 742 ,(2011) , 10.1111/J.1463-1318.2009.02167.X